amantadine has been researched along with biperiden in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (31.58) | 18.7374 |
| 1990's | 7 (36.84) | 18.2507 |
| 2000's | 2 (10.53) | 29.6817 |
| 2010's | 4 (21.05) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adkison, KK; Humphreys, JE; Mahar Doan, KM; Polli, JW; Serabjit-Singh, CJ; Shampine, LJ; Webster, LO; Wring, SA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Postma, JU; Van Tilburg, W | 1 |
| Parkenberg, H | 1 |
| Suitsu, N | 1 |
| Onodera, K; Shinoda, H | 1 |
| Bar, M; Graff, E; Isakov, M; Oberman, Z; Rabey, JM; Scharf, M | 1 |
| Bubovich, VI; Hegenscheid, B; Heider, H; Rosenthal, HA; Schöffel, M; Schroeder, C | 1 |
| Flechter, S; Graff, E; Oberman, Z; Rabey, JM; Vardi, J | 1 |
| Fincke, M; Gothóni, P; Lehtinen, M | 1 |
| Auff, E; Gradner, W; Schnaberth, G | 1 |
| Geraisy, N; Schwartz, M; Silver, H | 1 |
| Geraisy, N; Silver, H | 2 |
| Chwatal, K; Havelec, L; König, P; Riedl, F; Schubert, H; Schultes, H | 1 |
1 review(s) available for amantadine and biperiden
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
5 trial(s) available for amantadine and biperiden
| Article | Year |
|---|---|
[A computer-assisted EEG study on psychotropic properties of antiparkinsonian drugs].
Topics: Amantadine; Antiparkinson Agents; Biperiden; Bromocriptine; Electroencephalography; Glycolates; Humans; Levodopa; Male; Psychotropic Drugs; Thiophenes; Trihexyphenidyl | 1992 |
No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
Topics: Adult; Amantadine; Antipsychotic Agents; Biperiden; Cross-Over Studies; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Male; Parkinson Disease, Secondary; Placebos; Schizophrenia | 1995 |
Effects of biperiden and amantadine on memory in medicated chronic schizophrenic patients. A Double-blind cross-over study.
Topics: Adult; Amantadine; Biperiden; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Memory; Placebos; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1995 |
No difference in the effect of biperiden and amantadine on negative symptoms in medicated chronic schizophrenic patients.
Topics: Adult; Amantadine; Basal Ganglia Diseases; Biperiden; Chronic Disease; Cross-Over Studies; Dopamine Agents; Double-Blind Method; Female; Humans; Male; Parasympatholytics; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1995 |
Amantadine versus biperiden: a double-blind study of treatment efficacy in neuroleptic extrapyramidal movement disorders.
Topics: Amantadine; Biperiden; Double-Blind Method; Female; Humans; Male; Movement Disorders; Schizophrenia; Time Factors | 1996 |
13 other study(ies) available for amantadine and biperiden
| Article | Year |
|---|---|
Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cell Line; Cell Membrane Permeability; Central Nervous System Agents; Dogs; Drug Delivery Systems; Permeability; Pharmaceutical Preparations | 2002 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Visual hallucinations and delirium during treatment with amantadine (Symmetrel).
Topics: Aged; Amantadine; Benztropine; Biperiden; Delirium; Drug Eruptions; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Orphenadrine; Parkinson Disease | 1975 |
[Treatment of parkinsonism].
Topics: Amantadine; Benztropine; Biperiden; Humans; Levodopa; Orphenadrine; Parkinson Disease; Procyclidine; Trihexyphenidyl | 1976 |
Pharmacological characteristics of catalepsy induced by intracerebroventricular administration of histamine in mice: the importance of muscarinic step in central cholinergic neurons.
Topics: Amantadine; Animals; Atropine; Biperiden; Bromocriptine; Catalepsy; Histamine; Injections, Intraventricular; Levodopa; Male; Mice; Neurons; Promethazine; Receptors, Muscarinic; Scopolamine; Trihexyphenidyl | 1991 |
Bromocriptine blood levels after the concomitant administration of levodopa, amantadine and biperiden in Parkinson's disease.
Topics: Administration, Oral; Aged; Amantadine; Biperiden; Bromocriptine; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease, Secondary; Piperidines | 1990 |
The anticholinergic anti-Parkinson drug Norakin selectively inhibits influenza virus replication.
Topics: Amantadine; Animals; Antiviral Agents; Biperiden; Cell Line; Chick Embryo; Drug Interactions; Drug Resistance, Microbial; Genes, Viral; Hemagglutination, Viral; Hemolysis; Influenza A virus; Interferon Type I; Interferons; Measles virus; Mutation; Piperidines; Virus Replication | 1985 |
Selective regional effect of various neuroactive drugs on bromocriptine concentration in the brain of rats.
Topics: Amantadine; Animals; Biperiden; Brain Chemistry; Bromocriptine; Carbidopa; Diazepam; Haloperidol; Levodopa; Methysergide; Naloxone; Rats | 1986 |
Drugs for Parkinson's disease reduce tremor induced by physostigmine.
Topics: Amantadine; Animals; Antiparkinson Agents; Atropine; Biperiden; Bromocriptine; Male; Physostigmine; Pimozide; Rats; Rats, Inbred Strains; Tremor | 1983 |
[The Steel Richardson Olszewski-syndrome. A report on 3 further cases (author's transl)].
Topics: Amantadine; Biperiden; Bulbar Palsy, Progressive; Dementia; Dysarthria; Humans; Male; Middle Aged; Ophthalmoplegia; Syndrome | 1981 |